Professor and Chair, Department of Pharmacology and Clinical Pharmacology ; Founding Director of the Pharmacogenomics Research Center at Inje University College of Medicine, Busan, Korea
Dr. Jae-Gook Shin is currently a Professor and Chair of the department of Pharmacology and Clinical Pharmacology and founding Director of the Pharmacogenomics Research Center at Inje University College of Medicine, Busan, Korea. He is also Director of the Global Center of Excellence in Clinical Trials at Inje University Busan Paik Hospital. Dr. Shin is currently serving as the Chair of the Board of Directors for the Korean Society for Clinical Pharmacology and Therapeutics (KSCPT).
Dr. Shin received his Ph.D. in Pharmacology from Seoul National University School of Medicine in 1992, and MD degree from Inje University College of Medicine in 1986. Dr. Shin completed 2 years Clinical Pharmacology fellow training in the Division of Clinical Pharmacology at Georgetown University Medical Center, in Washington DC as a 1997 recipient of the Merck Sharp & Dohme International Fellowship in Clinical Pharmacology funded by the Merck Foundation.
Dr. Shin has published over 280 papers in clinical pharmacology including Pharmacogenomics and personalized medicine, clinical PK/PD, DM/PK and drug interaction, PK/PD modeling, and other clinical pharmacology areas. He has served as an editorial board member for several renowned international publications including Clinical Pharmacology and Therapeutics(CP&T), British Journal of Clinical Pharmacology(BJCP), Pharmacogenetics and Genomics, Pharmacogenomics J, Frontiers in Pharmacogenomics, Personalized Medicine, and more. Dr. Shin has served as Chair of the Organizing Committee for several national and international meetings, including the International Symposium on Pharmacogenomics and the 11th International ISSX meeting. Dr. Shin has also served for many academic societies and national/regional committees such as the IUPHAR Clinical Pharmacology Council and Pharmacogenetics Committee, the Korean Association of Clinical Trial Centers, and the Korean Network of South-Eastern Regional Clinical Trial Organization. He is a member of the trustee board of directors for the Korean National Enterprise for Clinical trials. Dr. Shin has received several awards including the Korean Federation of Science and Technology Societies’ Outstanding Research in Science and Technology Award and the Korean Society of Medical Science’s 7th Pfizer Medical Research.